Business Wire

CA-VELODYNE/SEOUL-ROBO

Share
Velodyne Showcases Lidar Solutions for Manufacturing and Supply Chain Operations at MODEX 2020

Velodyne Lidar, Inc. (Booth #6091), in collaboration with Seoul Robotics , will demonstrate how its smart, powerful lidar solutions advance automation and safety in manufacturing and supply chain solutions at MODEX 2020 in Atlanta, March 9-12. Velodyne will highlight lidar sensors that can be used in robotics, automated guided vehicles (AGV), forklifts and security applications. Velodyne lidar solutions can improve industrial automation, materials handling, yard management and distribution center operations.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200227005194/en/

At its MODEX booth, Velodyne will showcase the Puck 32MR™, a lidar sensor which produces a data-rich image with the ability to detect low reflectivity objects at a range of 120 meters. The sensor is optimized for outstanding indoor/outdoor performance, operating in a variety of light conditions. By combining high-resolution 3D perception with a broad vertical field of view, the Puck 32MR accurately detects crosswalks, curbs and obstacles in warehouse aisles for safe and efficient navigation in roadway, commercial and industrial settings.

Velodyne will also highlight the Velarray™, a powerful sensor solution to greatly improve automated safety. Its small, embeddable form factor enables the sensor to be seamlessly integrated into a variety of industrial and robotics equipment. The Velarray produces a robust directional image, day or night.

“As the demands for supply chain efficiency and safety increase and evolve, lidar technology is helping companies vastly improve manufacturing and logistics performance,” said Jon Barad, Vice President of Business Development, Velodyne Lidar. “Supply chain systems need to continue to become smarter and safer, more efficient and further automated. To address these requirements, companies are turning to lidar to play a key role in enabling the next generation of manufacturing and supply chain solutions.”

At Velodyne’s MODEX booth, Seoul Robotics will demonstrate the benefits and applications of Level 5 Control Tower solution, powered by its proprietary AI engine, SENSR™, which is optimized and available commercially to process Velodyne’s rich and reliable 3D data. Seoul Robotics uses artificial intelligence (AI) for detection, counting, classification and tracking of objects in real time. It can accurately track the location, coordinates, speed and direction of objects and predict their path, such as vehicles and people at a distribution center or manufacturing and logistics operation.

“As vehicles and material handling equipment are increasingly automated in logistics yards and distribution centers, industry must develop and deploy in parallel a robust and safe operating environment. This will resolve well-known challenges with trucks and equipment, such as blind spots and occlusion, in order to successfully realize the promised efficiency and economy,” said David Han, Seoul Robotics’ Managing Director of North America & Global Automotive. “Level 5 Control Tower equipped with Velodyne lidar enables exactly that – a robust and cost-effective infrastructure-based perception solution that monitors and guides the movement of automated and conventional vehicles within the entire yard – efficiently and safely.”

About Velodyne Lidar

Velodyne provides smart, powerful lidar solutions for autonomy and driver assistance. Headquartered in San Jose, Calif., Velodyne is known worldwide for its portfolio of breakthrough lidar sensor technologies. Velodyne’s founder, David Hall, invented real-time surround view lidar systems in 2005 as part of Velodyne Acoustics. Mr. Hall’s invention revolutionized perception and autonomy for automotive, new mobility, mapping, robotics, and security. Velodyne’s high-performance product line includes a broad range of sensing solutions, including the cost-effective Puck™, the versatile Ultra Puck™, the autonomy-advancing Alpha Prime™, the ADAS-optimized Velarray™, and the groundbreaking software for driver assistance, Vella™.

About Seoul Robotics

Seoul Robotics is a 3D Perception AI company that specializes in Lidar perception solutions, powered by its proprietary and versatile SENSR™ perception platform suite. Based in Seoul, South Korea with U.S. branch office in Ann Arbor, Michigan, Seoul Robotics is developing customers and projects in the ADAS/AV, Security, Smart Factory and Logistics, and Robotics markets worldwide. Seoul Robotics works collaboratively with partners across the value chain – including Lidar manufacturers, global automotive and industrial OEM’s and Tier 1 & 2 suppliers, engineering companies, and government customers – to advance perception solutions that make robots intelligent. Visit www.seoulrobotics.org for more information.

Link:

ClickThru

Social Media:

https://www.facebook.com/velodyneLiDAR/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

IonQ Partners with Italy’s National Strategy for Quantum Technology; Co-Founds Q-Alliance to Jointly Create Quantum Hub20.10.2025 13:05:00 CEST | Press release

Q-Alliance launch marks a key milestone in Italy’s digital transformation and the country’s ambitious quantum ecosystem goals IonQ (NYSE: IONQ), the world’s leading quantum company, today announced its role as a founding member of Q-Alliance, an ambitious new initiative to establish a world-class quantum computing hub in Lombardy, Italy. Formed in alignment with Italy’s National Strategy for Quantum Technologies, Q-Alliance brings together public and private partners committed to building a future-forward quantum ecosystem. The initiative – launched at the ComoLake2025 Digital Innovation Forum – combines the advanced quantum technology and expertise of IonQ with support from leading Italian scientific institutions and governmental stakeholders. Q-Alliance aims to accelerate breakthroughs in science, support Italy’s industrial transition, and ensure long-term digital sovereignty. “IonQ enables a fantastic opportunity for Italy to lead a ‘Quantum Renaissance’ with the potential to transf

Cooler Master Expands Its Thermal Excellence with Hyper 212 3DHP Series and V4 Alpha 3DHP Black20.10.2025 12:01:00 CEST | Press release

Reliable, Quiet Single-Tower Air Coolers Built on Patented 3DHP Cooler Master, a global leader in PC components and tech lifestyle solutions, today announced availability of the Hyper 212 3DHP series and the V4 Alpha 3DHP Black air coolers. Both use Cooler Master’s patented 3DHP Technology the company’s latest cooling innovation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251020694683/en/ The new air coolers from Cooler Master: the Hyper 212 3DHP series and the V4 Alpha 3DHP Black. “With 3DHP, we move past pipe-count and focus on results,” said Matteo Stracciari, GM of Cooler Master EU. “Less heat. More dependable performance. Less noise. More long-term reliability. All in compact single-tower builds.” 3DHP: Less is More 3DHP reengineers the heat pipe itself for better evaporation, condensation, and flow. A third pipe endpoint and a precision T-joint increase heat pickup and flow, turning fewer pipes into more effective

BeOne Medicines Presents New Data on TEVIMBRA in Lung Cancer at ESMO 202520.10.2025 12:00:00 CEST | Press release

New data from two pivotal TEVIMBRA studies – RATIONALE-307 and -312 – reinforce the PD-1 inhibitor’s proven clinical benefit in both NSCLC and ES-SCLCEarly data from investigational HPK1 inhibitor BGB-26808, in combination with TEVIMBRA, show promise in advanced solid tumors BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced the presentation of data from two pivotal Phase 3 trials – RATIONALE-307 and 312 – offering new evidence of the benefits of its PD-1 inhibitor, TEVIMBRA® (tislelizumab), at the European Society of Medical Oncology 2025 Congress (ESMO 2025) in Berlin, Germany, October 17-21. The results reinforce TEVIMBRA’s consistent and durable efficacy across lung cancer subtypes, including non-small cell lung cancer (NSCLC) and extensive-stage small cell lung cancer (ES-SCLC). In addition, the first clinical data from BeOne’s investigational HPK1 inhibitor, BGB-26808, as a single agent and in combination with TEVIMBRA, will b

SunRock Biopharma and Chime Biologics Announce Strategic Collaboration to Advance Development of Anti-CCR9 Antibody SRB520.10.2025 11:00:00 CEST | Press release

SunRock Biopharma, a biotechnology company focused on developing next-generation therapeutic antibodies, and Chime Biologics, a global leading contract development and manufacturing organization (CDMO), today announced a strategic collaboration for the development of SRB5, a novel anti-CCR9 monoclonal antibody targeting inflammatory bowel disease (IBD), with potential expansion into other immune-mediated inflammatory indications. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251019831972/en/ The scientific team of SunRock Biopharma. SRB5 is a humanized monoclonal antibody with enhanced ADCC properties, designed to selectively deplete CCR9+ cells involved in chronic intestinal inflammation. It is the latest advancement in SunRock’s anti-CCR9 platform and represents a significant advance in a selective therapeutic approach for treating diseases such as Crohn’s disease and ulcerative colitis. Through this partnership, SunRock

New Needle-Free Treatment Option for Life-Threatening Anaphylaxis, EURneffy®, Now Available in the UK20.10.2025 10:01:00 CEST | Press release

For decades, traditional adrenaline auto-injectors (AAIs) have been the only available treatment for anaphylaxis—a life-threatening allergic reaction.1,2 Yet from today, the UK’s first needle-free emergency anaphylaxis treatment, the EURneffy® nasal adrenaline spray, is available on prescription.3 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251020480135/en/ EURneffy® 2 mg nasal spray offers a simple-to-use,3,4 pocket-sized alternative to traditional AAIs, with the potential to transform the lives of those with severe allergies in the UK. It is designed to be portable and ready-to-use in emergencies,3 offering a new alternative to traditional AAIs, including for those who struggle with needles or need a more convenient option they can rely on. EURneffy® also has a longer shelf life and can withstand temperature changes better than traditional AAIs,3,5 meaning fewer trips to the GP for a new prescription. Simon Williams, Ch

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye